Adam is Manager Population & Public Health Research, where he is responsible for modeling and generation of real-world evidence (RWE) for the health impact of adult smokers switching to our smoke-free products. Besides supervising his highly qualified team of experts on modeling, he contributes to regulatory dossiers, provides project support to medical affairs, health economics, external affairs and IT, as well as acts as an expert on epidemiology, study planning, and RWE.
Adam holds master’s degrees in Economic Sociology from Corvinus University of Budapest (Hungary) and Information and Data Science from UC Berkeley School of information (California, United States). He completed his PhD research at the Max Planck Institute of Demographic Research and earned a PhD from University of Rostock (Germany).
Early in his career he taught courses on biostatistics, mathematical demography, and programming and has published in high-ranking journals such as Nature, Aging Cell, Proceedings of the National Academy of Sciences, and Scandinavian Actuarial Journal. Later, he joined the pharmaceutical industry and focused on understanding real-world statistics with the aim of turning them into business or scientific insights. He is an experienced data scientist who has worked on business implementation of machine learning methods. He has been working in multiple roles with a cross-functional reach across the whole manufacturing and pharmaceutical value chain starting with early research, clinical product development, regulatory submissions, scientific publishing, then ending with safety reporting, public messaging, and commercialization.